the specific effects of u 46619 ( 9,11-dideoxy,9 alpha-11 alpha-methanoepoxyprostaglandin f2 alpha ) , thromboxane a2-prostaglandin h2 ( txa2/pgh2 ) analogue , on human platelet shape change , myosin light-chain phosphorylation , serotonin release , fibrinogen receptor exposure , and platelet aggregation were measured and compared with binding of [ 3h ] u 46619 to platelets .
C0919509
h2
C0086418
human